Literature DB >> 28686854

REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis.

Yavuz Bayram1, Janson J White1, Nursel Elcioglu2, Megan T Cho3, Neda Zadeh4, Asuman Gedikbasi5, Sukru Palanduz5, Sukru Ozturk5, Kivanc Cefle5, Ozgur Kasapcopur6, Zeynep Coban Akdemir1, Davut Pehlivan7, Amber Begtrup3, Claudia M B Carvalho1, Ingrid Sophie Paine1, Ali Mentes8, Kivanc Bektas-Kayhan9, Ender Karaca1, Shalini N Jhangiani10, Donna M Muzny10, Richard A Gibbs11, James R Lupski12.   

Abstract

Hereditary gingival fibromatosis (HGF) is the most common genetic form of gingival fibromatosis that develops as a slowly progressive, benign, localized or generalized enlargement of keratinized gingiva. HGF is a genetically heterogeneous disorder and can be transmitted either as an autosomal-dominant or autosomal-recessive trait or appear sporadically. To date, four loci (2p22.1, 2p23.3-p22.3, 5q13-q22, and 11p15) have been mapped to autosomes and one gene (SOS1) has been associated with the HGF trait observed to segregate in a dominant inheritance pattern. Here we report 11 individuals with HGF from three unrelated families. Whole-exome sequencing (WES) revealed three different truncating mutations including two frameshifts and one nonsense variant in RE1-silencing transcription factor (REST) in the probands from all families and further genetic and genomic analyses confirmed the WES-identified findings. REST is a transcriptional repressor that is expressed throughout the body; it has different roles in different cellular contexts, such as oncogenic and tumor-suppressor functions and hematopoietic and cardiac differentiation. Here we show the consequences of germline final-exon-truncating mutations in REST for organismal development and the association with the HGF phenotype.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RE1-silencing transcription factor; REST; gingival fibromatosis; mosaic mutation; nonsense-mediated decay; whole-exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28686854      PMCID: PMC5501868          DOI: 10.1016/j.ajhg.2017.06.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

Review 1.  Transcriptional regulation: cancer, neurons and the REST.

Authors:  Judy M Coulson
Journal:  Curr Biol       Date:  2005-09-06       Impact factor: 10.834

Review 2.  Drug-induced gingival overgrowth--a review.

Authors:  Masatoshi Kataoka; Jun-ichi Kido; Yasuo Shinohara; Toshihiko Nagata
Journal:  Biol Pharm Bull       Date:  2005-10       Impact factor: 2.233

3.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

Review 4.  Chromatin crosstalk in development and disease: lessons from REST.

Authors:  Lezanne Ooi; Ian C Wood
Journal:  Nat Rev Genet       Date:  2007-07       Impact factor: 53.242

5.  EWS-FLI-1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology.

Authors:  Zhichao Zhou; Ling Yu; Eugenie S Kleinerman
Journal:  Cancer       Date:  2014-01-10       Impact factor: 6.860

6.  RE1-silencing Transcription Factor (REST) Is Required for Nuclear Reprogramming by Inhibiting Transforming Growth Factor β Signaling Pathway.

Authors:  Qing-Ran Kong; Bing-Teng Xie; Heng Zhang; Jing-Yu Li; Tian-Qing Huang; Ren-Yue Wei; Zhong-Hua Liu
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

7.  The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.

Authors:  C J Schoenherr; D J Anderson
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

8.  REST is a novel prognostic factor and therapeutic target for medulloblastoma.

Authors:  Pete Taylor; Jason Fangusaro; Veena Rajaram; Stewart Goldman; Irene B Helenowski; Tobey MacDonald; Martin Hasselblatt; Lars Riedemann; Alvaro Laureano; Laurence Cooper; Vidya Gopalakrishnan
Journal:  Mol Cancer Ther       Date:  2012-07-30       Impact factor: 6.261

9.  GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.

Authors:  Nara Sobreira; François Schiettecatte; David Valle; Ada Hamosh
Journal:  Hum Mutat       Date:  2015-08-13       Impact factor: 4.878

10.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.

Authors:  Helga Thorvaldsdóttir; James T Robinson; Jill P Mesirov
Journal:  Brief Bioinform       Date:  2012-04-19       Impact factor: 11.622

View more
  19 in total

1.  Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles.

Authors:  Zeynep Coban-Akdemir; Janson J White; Xiaofei Song; Shalini N Jhangiani; Jawid M Fatih; Tomasz Gambin; Yavuz Bayram; Ivan K Chinn; Ender Karaca; Jaya Punetha; Cecilia Poli; Eric Boerwinkle; Chad A Shaw; Jordan S Orange; Richard A Gibbs; Tuuli Lappalainen; James R Lupski; Claudia M B Carvalho
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

2.  Biallelic and De Novo Variants in DONSON Reveal a Clinical Spectrum of Cell Cycle-opathies with Microcephaly, Dwarfism and Skeletal Abnormalities.

Authors:  Ender Karaca; Jennifer E Posey; Bret Bostwick; Pengfei Liu; Alper Gezdirici; Gozde Yesil; Zeynep Coban Akdemir; Yavuz Bayram; Frederike L Harms; Peter Meinecke; Malik Alawi; Carlos A Bacino; V Reid Sutton; Fanny Kortüm; James R Lupski
Journal:  Am J Med Genet A       Date:  2019-08-13       Impact factor: 2.802

3.  Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.

Authors:  M Cecilia Poli; Frédéric Ebstein; Sarah K Nicholas; Marietta M de Guzman; Lisa R Forbes; Ivan K Chinn; Emily M Mace; Tiphanie P Vogel; Alexandre F Carisey; Felipe Benavides; Zeynep H Coban-Akdemir; Richard A Gibbs; Shalini N Jhangiani; Donna M Muzny; Claudia M B Carvalho; Deborah A Schady; Mahim Jain; Jill A Rosenfeld; Lisa Emrick; Richard A Lewis; Brendan Lee; Barbara A Zieba; Sébastien Küry; Elke Krüger; James R Lupski; Bret L Bostwick; Jordan S Orange
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

4.  Hereditary gingival fibromatosis in children: a systematic review of the literature.

Authors:  Eirini Boutiou; Ioannis A Ziogas; Dimitrios Giannis; Aikaterini-Elisavet Doufexi
Journal:  Clin Oral Investig       Date:  2020-11-13       Impact factor: 3.573

5.  Identifying the focuses of hereditary gingival fibromatosis with bioinformatics strategies.

Authors:  Fumin Zheng; Guangtian Chen; Hui Deng
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

6.  Unusual clinical and histologic findings in a child with mixed dentition with hereditary gingival fibromatosis: a case report.

Authors:  Han Gao; Jun Liang; Xiaoxue Xia; Zhaoming Deng; Zhaoqiang Zhang
Journal:  Transl Pediatr       Date:  2020-02

7.  Identification of likely pathogenic and known variants in TSPEAR, LAMB3, BCOR, and WNT10A in four Turkish families with tooth agenesis.

Authors:  Renqian Du; Nuriye Dinckan; Xiaofei Song; Zeynep Coban-Akdemir; Shalini N Jhangiani; Yeliz Guven; Oya Aktoren; Hulya Kayserili; Lauren E Petty; Donna M Muzny; Jennifer E Below; Eric Boerwinkle; Nan Wu; Richard A Gibbs; Jennifer E Posey; James R Lupski; Ariadne Letra; Z Oya Uyguner
Journal:  Hum Genet       Date:  2018-07-26       Impact factor: 4.132

8.  Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness.

Authors:  Yoko Nakano; Michael C Kelly; Atteeq U Rehman; Erich T Boger; Robert J Morell; Matthew W Kelley; Thomas B Friedman; Botond Bánfi
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

Review 9.  Insights into genetics, human biology and disease gleaned from family based genomic studies.

Authors:  Jennifer E Posey; Anne H O'Donnell-Luria; Jessica X Chong; Tamar Harel; Shalini N Jhangiani; Zeynep H Coban Akdemir; Steven Buyske; Davut Pehlivan; Claudia M B Carvalho; Samantha Baxter; Nara Sobreira; Pengfei Liu; Nan Wu; Jill A Rosenfeld; Sushant Kumar; Dimitri Avramopoulos; Janson J White; Kimberly F Doheny; P Dane Witmer; Corinne Boehm; V Reid Sutton; Donna M Muzny; Eric Boerwinkle; Murat Günel; Deborah A Nickerson; Shrikant Mane; Daniel G MacArthur; Richard A Gibbs; Ada Hamosh; Richard P Lifton; Tara C Matise; Heidi L Rehm; Mark Gerstein; Michael J Bamshad; David Valle; James R Lupski
Journal:  Genet Med       Date:  2019-01-18       Impact factor: 8.822

10.  Phen2Gene: rapid phenotype-driven gene prioritization for rare diseases.

Authors:  Mengge Zhao; James M Havrilla; Li Fang; Ying Chen; Jacqueline Peng; Cong Liu; Chao Wu; Mahdi Sarmady; Pablo Botas; Julián Isla; Gholson J Lyon; Chunhua Weng; Kai Wang
Journal:  NAR Genom Bioinform       Date:  2020-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.